Compound News and Research

RSS

Fungal compound galiellalactone may combat prostate cancer

Can a substance from a fungus that grows on decaying trees provide a cure for aggressive prostate cancer? This is the hope of researchers at Lund University in Sweden.

3 Apr 2007

Compounds derived from blue agave may be more effective way to deliver drugs to the colon

Compounds derived from the blue agave, a fruit used to make tequila, shows promise in early laboratory studies as a natural, more effective way to deliver drugs to the colon than conventional drug-carriers, according to chemists at the University of Guadalajara in Mexico.

3 Apr 2007

Advances in clinical cardiology

Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.

3 Apr 2007

Biobased alternative for critical component of many polymer products

Virginia Tech chemists are looking for biobased alternatives and environmentally friendly reaction pathways to replace a toxic intermediate that is a critical component of many polymer products.

3 Apr 2007

New blood thinner thrombin-receptor antagonist may work without bleeding risk

When studying a new blood thinner, one of the first signs the drug is working is seeing a slight increase in minor bleeding, nose bleeds and bruising, an inconvenient side effect of preventing the blood clots that are the leading cause of heart attack and stroke.

3 Apr 2007

New contrast agent selectively targets and highlights malignant micro-calcifications in the breast

Harvard Medical School researchers are working on a new, simpler way to distinguish malignant tumors from non-cancerous masses when screening for breast cancer.

2 Apr 2007

Study results on bifeprunox in patients with schizophrenia

Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.

2 Apr 2007

Intelligent materials substitute for bone tissue

More than half a million people in the European Union and a million in the United States suffer from disorders in or serious defects of some part of their bone structure.

2 Apr 2007

New discoveries offer promise for cholesterol drugs

New discoveries offer promise for developing drugs that improve on the therapeutic profile of niacin, the inexpensive, time-tested B-vitamin that boosts levels of HDL cholesterol, the good cholesterol with the potential to protect people against heart attacks and stroke, scientists report.

1 Apr 2007

Natural mechanism for immune suppression may lead to new cancer drugs

A natural mechanism pirated by tumors and HIV to evade the immune response is opening the door to better treatment for these conditions, researchers say.

31 Mar 2007

Crateagus extract postpones cardiac events in patients with congestive heart failure

An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.

30 Mar 2007

Curecumin - potential treatment for lung cancer

Bioponic Phytoceuticals has announced that its Curecumin (a Bioresonant Phytotherapeutic form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.

28 Mar 2007

Newly discovered peptide could help transplant for diabetes

A peptide developed by scientists at Weill Cornell Medical College may expand the availability and durability of islet cell transplant for patients with type-1 diabetes, which is characterized by a lack of these insulin-producing cells.

21 Mar 2007

Curry related compound shows promise against Kennedy's disease

Scientists who focus on the molecular signaling that underlies prostate cancer have discovered a compound that shows promise against a debilitating neurodegenerative condition known as Kennedy's disease, which is caused by a mutant gene.

21 Mar 2007

A food supplement that could prevent the development of diabetes and atherosclerosis

The health benefits of cutting down on dietary saturated fatty acids and including higher levels of unsaturated fatty acids are well documented. Nutritional research is focusing on the effects of incorporating these healthier fatty acids, such as conjugated linoleic acid (CLA), into animal and human diets. CLA is present in dairy products and meat from ruminants and in very low amounts in our bodies.

11 Mar 2007

Lilly to acquire neuroscience drug discovery co. Hypnion

Eli Lilly and Company and Hypnion, Inc. today announced that they have signed a definitive merger agreement whereby Lilly will acquire Hypnion, a privately held neuroscience drug discovery company focused on sleep disorders.

5 Mar 2007

Ultrafine hydrogel nanoparticles: synthetic approach and therapeutic application in living cells

Ultrafine nanoparticles made of a lacy web of polymer and tiny pockets of water may prove to be an ideal vehicle for delivering light-activated drugs to tumors.

5 Mar 2007

Garlic - a tasty addition to food but useless for lowering cholesterol

Researchers at Stanford University School of Medicine say they have found that eating garlic raw or taking it in supplement form does not lower "bad" cholesterol levels.

28 Feb 2007

PPD licenses dyslipidemia statin from Ranbaxy

Ranbaxy Laboratories and PPD, Inc. have announced that PPD has acquired an exclusive worldwide license to develop, manufacture and market Ranbaxy's novel statin for the treatment of dyslipidemia.

27 Feb 2007

Garlic does not lower LDL cholesterol

Three forms of garlic - including raw garlic and two types of commercial garlic supplements - did not significantly reduce low-density lipoprotein (LDL or "bad") cholesterol during a six-month trial, according to results published in the February 26 issue of Archives of Internal Medicine.

27 Feb 2007